|
|
Breisacher Str. 117
Freiburg, D-79106 Germany
phone:(49) 761 206 1780
fax:(49) 761 206 1781
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.proqinase.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Protein kinase inhibitors for cancer treatment. |
|
| Management |
| Christoph Schchtele, PhD, Managing Director; Dipl.-Kfm. Arno Fritzen, Managing Director; Michael Kubbutat, PhD, Head Research & Development; Alexander Baumann, PhD, Head Sales & Business Development |
| |
|
|
| |
|
| Keywords |
| biotechnology, protein, kinase, inhibitors, cancer, drug, pharmaceutical, biotech, tumor, robotic, system, cellular, in vivo |
|
|
|
| Description |
|
ProQinase is a biotechnology company focusing on the development of protein kinase inhibitors for cancer treatment. |
|
| Technology / Differentiation |
| The Integrated Technology Platform Protein Kinases features technologies for the identification and validation of protein kinases as novel targets for tumor therapy, more than 50 recombinant protein kinases, a robotic system for high-throughput screening and selectivity profiling of chemical substances, cellular test systems and in vivo tumor models. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members